Product Information
TADALAFIL 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1134 per EA under NDC 00480230956. Its NADAC has been published 143 times since Feb 28, 2024.
FDA first approved this application on Mar 29, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Tadalafil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480230956
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA205885FDA Approved
3/29/2019
TE Code
AB1
On Market Since
1/16/2024
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 5 MG TABLET has been published 143 times since Feb 28, 2024, and over the history we have for it it has declined 22.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1134 per EA |
|---|---|
| All-time high | $0.1681 (Sep 11, 2024) |
| All-time low | $0.0842 (Nov 20, 2024) |
| 52-week high | $0.1162 |
| 52-week low | $0.1014 |
| Median price | $0.1116 |
| Average price | $0.1154 |
| Largest weekly change | +47.6% (Aug 21, 2024) |
| Weeks tracked | 143 |
| Tracking since | Feb 28, 2024 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tadalafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TADALAFIL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1134 per EA (NDC 00480230956), effective Nov 18, 2026.
How has the price of TADALAFIL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has declined 22.2%. It has been tracked across 143 weekly CMS publications since Feb 28, 2024.
What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?
Since Feb 28, 2024, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.0842 (Nov 20, 2024) to a high of $0.1681 (Sep 11, 2024), with a median of $0.1116 per EA.
Are there cheaper alternatives to TADALAFIL 5 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 5 MG TABLET, is $0.1043 per EA — about 8% below TADALAFIL 5 MG TABLET.
Who manufactures TADALAFIL 5 MG TABLET?
TADALAFIL 5 MG TABLET (NDC 00480230956) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.